Targeting Key Molecular Mechanisms in Triple-Negative Breast Cancer Therapies with Natural Compounds
Natural compounds are a promising supplementary method for TNBC therapy due to their ability to target unregulated pathways and overcome therapeutic resistance. Nevertheless, challenges such as pharmacokinetics, limited bioavailability, and a lack of clinical validation persist. Future research should focus on combinatorial regimens, nanocarrier-based delivery technologies, and biomarker-guided clinical trials to develop successful TNBC treatments.
Authors
- Nihar Ranjan Kar (ORCID: https://orcid.org/0000-0001-9128-2506)
- Santosh Kumar Dash (ORCID: https://orcid.org/0000-0002-0703-812X)
- Nezar Cherrada (ORCID: https://orcid.org/0000-0002-4153-6958)
- Uttam Prasad Panigrahy (ORCID: https://orcid.org/0000-0002-8142-044X)
- Md. Fahim Faysal (ORCID: https://orcid.org/0009-0009-9082-2350)
- Mehrukh Zehravi (ORCID: https://orcid.org/0000-0003-3156-2826)
- A Padhan
- Asim Khan (ORCID: https://orcid.org/0000-0001-6419-6696)
- Talha Bin Emran (ORCID: https://orcid.org/0000-0003-3188-2272)
- Sherouk Hussein Sweilam (ORCID: https://orcid.org/0000-0002-5352-4778)
- Md. Zia Uddin (ORCID: https://orcid.org/0000-0002-0606-0966)
- Md Al Amin (ORCID: https://orcid.org/0009-0008-8981-9667)
- Safia Obaidur Rab
Institutions
- Prince Sattam Bin Abdulaziz University (SA)
- Daffodil International University (BD)
- Buraydah Colleges (SA)
- Hindu College of Pharmacy (IN)
- Centre Hospitalo-Universitaire Bab El Oued (DZ)
- University of Eloued (DZ)
- Centurion University of Technology and Management (IN)
- Assam Down Town University (IN)
- Life University (US)
- Egyptian Russian University (EG)
- King Khalid University (SA)
- University of Science and Technology Chittagong (BD)
Publication Details
- Journal
- Current Pharmaceutical Design
- Published
- 2025-10-14
- DOI
- https://doi.org/10.2174/0113816128411154250918060514
- Citations
- 1
- Primary Topic
- Curcumin's Biomedical Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.59